Aspire Biopharma Holdings, Inc. Liquidation Value
ASBP
Other
Cash & Equivalents
$2.01M
As of 2025-12-31
Current Price: N/A
Key Metrics
Cash Liquidation Value
Cash minus Total Obligations
Cash: $2.01M
Total Obligations: -$7.76M
$-5.75M
Per share: $-1.63
Period: 2025-12-31
Liquid Liquidation Value
Cash + AR minus Total Obligations
Cash: $2.01M
AR: $0
Total Obligations: -$7.76M
$-5.75M
Per share: $-1.63
Period: 2025-12-31
Operating Liquidation Value
Cash + AR + Inventory minus Total Obligations
Cash: $2.01M
AR: $0
Inventory: $253,160
Total Obligations: -$7.76M
$-5.50M
Per share: $-1.56
Period: 2025-12-31
Build your own liquidation scenario
Adjust asset discounts and liability assumptions to see how assumptions affect the numbers.
Liquidation Ladder
| Metric | Total | Per Share |
|---|---|---|
| Cash Liquidation Value | $-5.75M | $-1.63 |
| Liquid Liquidation Value | $-5.75M | $-1.63 |
| Operating Liquidation Value | $-5.50M | $-1.56 |
Key Components (as of 2025-12-31)
| Cash & Equivalents | $2.01M |
| Accounts Receivable | N/A |
| Inventory | $253,160 |
| Current Liabilities | $7.59M |
| Long-term Debt | $163,817 |
| Op. Lease Liability | N/A |
| Finance Lease | N/A |
| Shares Outstanding | 3.5M |
Explore all 275 XBRL tags and build your own scenario → Open Calculator
Historical
| Period | Cash | AR | Inventory | AP | Curr Liab | LT Debt | Op Lease | Fin Lease |
|---|---|---|---|---|---|---|---|---|
| 2025-12-31 | $2.01M | N/A | $253,160 | $1.01M | $7.59M | $163,817 | N/A | N/A |
| 2025-09-30 | $3.90M | N/A | $35,437 | $1.06M | $13.86M | $9.69M | N/A | N/A |
| 2025-06-30 | $412,466 | N/A | N/A | $1.35M | $10.56M | N/A | N/A | N/A |
▼ Community Notes